Author:
Harter Philipp,Heitz Florian,du Bois Andreas
Publisher
Springer International Publishing
Reference26 articles.
1. Wagner U, Harter P, Hilpert F, et al. S3-guideline on diagnostics, therapy and follow-up of malignant ovarian tumours: short version 1.0 – AWMF registration number: 032/035OL, june 2013. Geburtshilfe Frauenheilkd. 2013;73(9):874–89.
2. Lhommé C, Morice P, Planchamp F, et al. Clinical practice guidelines 2008 for the surgical treatment, medical first-line and consolidation treatments of patients with epithelial ovarian cancer–update. According to the methodology of Standards, Options: Recommendations (SOR). Bull Cancer. 2008;95(9):881–6.
3. Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: european organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst. 2003;95:113–25.
4. Chan JK, Munro EG, Cheung MK, et al. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol. 2007;109:12–9.
5. du Bois A, Rochon J, Lamparter C, Pfisterer J. The quality assurance program of the AGO organkommission OVAR (QS-OVAR): pattern of care and reality in Germany 2001. Zentralbl Gynakol. 2005;127(1):9–17.